Monsanto Report issue

For profit Phase 1 Phase 2
Founded: St Louis MO United States (1901)
Status: Acquired by Pharmacia (1999) → now Pfizer (2003)

Organization Overview

First Clinical Trial
2010
NCT01369550
First Marketed Drug
1987
clorazepate (tranxene)
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Monsanto Company, LLC

Active Ingredients

Marketed Drugs (1)

clorazepate (tranxene) (1987)

Drugs in Phase 2 Trials (3)

Key: Monsanto (0) Acquired (3)

glycovir (Celgosivir) (1 trial)

miglustat (zavesca) (3 trials)

zidovudine (retrovir) (3 trials)

Drugs in Phase 1 Trials (2)

Key: Monsanto (0) Acquired (2)

lamotrigine (lamictal) (1 trial)

rivaroxaban (xarelto) (1 trial)

Drugs in Other Trials (2)

broccoli (1 trial)

eicosapentanoic acid (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 8
  • # of Trial APIs: 7